Search - tctmd.com

Displaying 21 - 40 of 358

Sort: Relevancy | Date

Two Trials Boost Intra-arterial Lytics After Stroke Thrombectomy

News Conference News ISC 2025

Two Trials Boost Intra-arterial Lytics After Stroke Thrombectomy

February 11, 2025

Recent ICD Implant Not a Risk for Car Crashes, but There Are Caveats

News Daily News

Recent ICD Implant Not a Risk for Car Crashes, but There Are Caveats

February 04, 2025

Immediate Angiography in OHCA Without STEMI Could Harm: TOMAHAWK and COACT

News Daily News

Immediate Angiography in OHCA Without STEMI Could Harm: TOMAHAWK and COACT

December 27, 2024

Obesity Trends May Be Going in the Right Direction for the First Time in a Decade

News Daily News

Obesity Trends May Be Going in the Right Direction for the First Time in a Decade

December 18, 2024

Embolic Protection Benefits Varied by Geography in PROTECTED TAVR

News Conference News TCT 2024

Embolic Protection Benefits Varied by Geography in PROTECTED TAVR

October 31, 2024

PEERLESS: FlowTriever Tops Catheter-Directed Thrombolysis for Acute PE

News Conference News TCT 2024

PEERLESS: FlowTriever Tops Catheter-Directed Thrombolysis for Acute PE

October 29, 2024

EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis

News Conference News TCT 2024

EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis

Michael O'Riordan

October 28, 2024

MACE in CV Trials: Has the Outcome Outlived Its Role?

News Conference News EACTS 2024

MACE in CV Trials: Has the Outcome Outlived Its Role?

Yael L. Maxwell

October 11, 2024

FINEARTS-HF: Benefit of Finerenone Extends to HFmrEF and HFpEF Patients

News Conference News ESC 2024

FINEARTS-HF: Benefit of Finerenone Extends to HFmrEF and HFpEF Patients

Michael O'Riordan

September 01, 2024

Trial Challenges Continuation of Oral Anticoagulants During TAVI

News Conference News ESC 2024

Trial Challenges Continuation of Oral Anticoagulants During TAVI

August 31, 2024

Tri.Fr Trial Affirms Quality-of-Life Impact of Tricuspid TEER

News Conference News ESC 2024

Tri.Fr Trial Affirms Quality-of-Life Impact of Tricuspid TEER

August 31, 2024

Leaks After LAAO Do Matter, Experts Agree

News Conference News NY Valves 2024

Leaks After LAAO Do Matter, Experts Agree

June 10, 2024

POLMIDES: Hybrid Revascularization Bests CABG For 10-Year Survival

News Conference News EuroPCR 2024

POLMIDES: Hybrid Revascularization Bests CABG For 10-Year Survival

Yael L. Maxwell

May 22, 2024

PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3

News Conference News EuroPCR 2024

PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3

Yael L. Maxwell

May 17, 2024

TAVI, Surgery Look Similar Long-term Across Risk Spectrum: Meta-analysis

News Conference News EuroPCR 2024

TAVI, Surgery Look Similar Long-term Across Risk Spectrum: Meta-analysis

Michael O'Riordan

May 16, 2024

Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids

News Conference News EuroPCR 2024

Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids

Michael O'Riordan

May 15, 2024

Radial PCI Benefits Seen in Real-world Analysis, Mirroring RCTs

News Conference News SCAI 2024

Radial PCI Benefits Seen in Real-world Analysis, Mirroring RCTs

May 10, 2024

Event Rates, Effect Sizes Often Overestimated in Major CV Trials

News Daily News

Event Rates, Effect Sizes Often Overestimated in Major CV Trials

May 09, 2024

BASIL-3: More Questions Than Answers About Drug-Coated Devices in CLTI

News Daily News

BASIL-3: More Questions Than Answers About Drug-Coated Devices in CLTI

April 24, 2024

Interatrial Shunt Falls Short in Sham-Controlled RELIEVE-HF

News Conference News ACC 2024

Interatrial Shunt Falls Short in Sham-Controlled RELIEVE-HF

Michael O'Riordan

April 06, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.